GRST Ethema Health Corporation

Fundamentals / CIK 0000792935 / USD

Ethema Health Corporation reported $18.76M in revenue and a net loss of $2.18M for the fiscal year ended December 31, 2025 (up 211.9% year over year), with a -1.4% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open GRST in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2015 to 2025), reported in USD.

$20.07M$10.04M$0-$15.59MFY 2015 Net Income: -$1.16M2015FY 2016 Net Income: -$261K2016FY 2018 Revenue: $433KFY 2018 Net Income: -$8.18M2018FY 2019 Revenue: $360KFY 2019 Net Income: -$14.96M2019FY 2020 Revenue: $339KFY 2020 Net Income: $3.08M2020FY 2021 Revenue: $1.94MFY 2021 Net Income: -$1.54M2021FY 2022 Revenue: $4.82MFY 2022 Net Income: $295K2022FY 2023 Revenue: $5.34MFY 2023 Net Income: $1.01M2023FY 2024 Revenue: $6.02MFY 2024 Net Income: -$2.06M2024FY 2025 Revenue: $18.76MFY 2025 Net Income: -$2.18M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $18.76M $6.02M $5.34M $4.82M $1.94M $339K $360K $433K -- --
Total Operating Expenses $19.02M $7.35M $5.89M $4.33M $1.94M $502K -- -- -- --
Operating Income -$260K -$1.33M -$542K $489K $2.1K -$163K -$4.20M -$2.88M -$791K -$450K
EBITDA $552K -$866K -$43K $1.03M $327K -$42K -$3.98M -$2.61M -- --
Interest Income $3.9K $2.3K $676 $78 -- $629 $17K $5.3K -- --
Interest Expense -- -- -- -- -- $631K $1.08M $697K $30K $20K
Income Before Tax -$2.23M -$2.17M $614K $407K -$1.85M $3.08M -- -- -- --
Income Tax Expense -$53K -- -$392K -$112K $281K -- -- -- -- --
Net Income -$2.18M -$2.06M $1.01M $295K -$1.54M $3.08M -$14.96M -$8.18M -$261K -$1.16M
Basic EPS $0.00 $0.00 $0.00 -- -- $0.00 -$0.11 -$0.07 -- -$0.02
Diluted EPS $0.00 $0.00 $0.00 -- -- $0.00 -$0.11 -$0.07 -- -$0.02
Basic Shares Outstanding 7.73B 5.61B 3.73B -- -- 1.59B 136.2M 123.9M 48.3M 47.2M
Diluted Shares Outstanding 7.73B 5.61B 3.90B -- -- 2.05B 136.2M 123.9M 48.3M 47.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue $4.81M $5.53M $4.91M $3.52M $1.47M $1.76M $1.49M $1.30M
Total Operating Expenses $5.18M $4.98M $4.70M $4.17M $1.57M $2.48M $1.77M $1.53M
Operating Income -$368K $546K $209K -$647K -$103K -$724K -$278K -$229K
EBITDA -$162K $752K $413K -$451K $18K -$601K -$165K -$118K
Interest Income $193 $2.0K $466 $1.2K $428 $766 $523 $575
Income Before Tax -$1.08M $53K -$309K -$897K -$326K -$1.00M -$465K -$374K
Income Tax Expense -$13K -$13K -$13K -$12K -- -- -- --
Net Income -$1.06M $66K -$296K -$885K -$326K -$1.00M -$363K -$374K
Basic EPS -- $0.00 $0.00 $0.00 -- $0.00 $0.00 $0.00
Diluted EPS -- $0.00 $0.00 $0.00 -- $0.00 $0.00 $0.00
Basic Shares Outstanding -- 7.73B 7.73B 7.73B -- 7.21B 3.73B 3.73B
Diluted Shares Outstanding -- 7.73B 7.73B 7.73B -- 7.21B 3.73B 3.73B

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $60K $245K $69K $141K $49K $90K $3.0K $25K $4.8K $174
Cash & Short-Term Investments $60K $245K $69K $141K $49K $90K $3.0K $25K $4.8K $174
Accounts Receivable, Net $1.45M $261K $313K $337K $176K $3.1K $106K $203K -- $184K
Other Current Assets -- -- $3.0K $20K $17K $132K $120K -- -- --
Total Current Assets $1.56M $529K $403K $543K $272K $935K $255K $408K $276K $220K
Property, Plant & Equipment, Net $1.38M $700K $508K $2.97M $3.01M $2.88M $5.78M -- -- $193K
Goodwill $3.43M -- -- -- -- -- -- -- -- --
Intangible Assets $2.97M $537K $895K $1.25M $1.61M -- -- -- -- --
Total Non-Current Assets $27.21M $11.63M $11.12M $6.02M $6.28M $2.89M $2.96M $12.26M $184K $72K
Total Assets $28.77M $12.16M $11.52M $6.56M $6.55M $3.82M $3.21M $12.67M $460K $292K
Short-Term Debt $4.55M $3.97M $4.42M $461K $122K $115K $107K -- -- $22K
Other Current Liabilities $273K $265K $212K -- -- -- -- -- -- --
Total Current Liabilities $15.36M $9.65M $8.30M $13.29M $13.52M $13.86M $18.58M $13.68M $3.64M $3.42M
Total Non-Current Liabilities $23.04M $9.96M $9.42M $2.11M $2.49M $4.58M $4.66M $6.71M $0 $8.8K
Total Liabilities $38.40M $19.62M $17.72M $15.40M $16.01M $18.45M $23.23M $20.39M $3.64M $3.42M
Total Debt (incl. Leases) $24.20M $14.24M $13.87M $1.99M $1.90M $115K $107K -- -- $22K
Common Stock $77.26M $77.29M $37.29M $37.29M $35.79M $20.27M $1.55M $1.24M $487K $477K
Retained Earnings -$46.60M -$44.42M -$42.36M -$43.48M -$44.10M -$42.46M -$45.49M -- -$20.98M --
Accumulated Other Comp. Income -- -- -- -$5.1K -- -- -- -- -- --
Total Stockholders' Equity -$9.64M -$7.46M -$6.20M -$9.23M -$9.86M -$15.73M -$20.02M -$7.72M -$3.18M -$3.13M
Total Equity -$9.64M -$7.46M -$6.20M -$9.23M -$9.86M -$15.03M -$20.02M -$7.72M -$3.18M -$3.13M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Cash & Cash Equivalents $60K $114K $442K $210K $245K $61K $31K $137K
Cash & Short-Term Investments $60K $114K $442K $210K $245K $61K $31K $137K
Accounts Receivable, Net $1.45M $2.44M $1.53M $1.04M $261K $381K $273K $357K
Other Current Assets -- $19 $2.5K $3.2K -- $1.5K $1.5K $3.2K
Total Current Assets $1.56M $2.61M $2.01M $1.27M $529K $472K $345K $510K
Property, Plant & Equipment, Net $1.38M $1.32M $1.31M $1.30M $700K $756K $763K $519K
Goodwill $3.43M $3.49M $3.57M $3.57M -- -- -- --
Intangible Assets $2.97M $3.11M $3.25M $3.40M $537K $626K $716K $805K
Total Non-Current Assets $27.21M $27.66M $26.89M $27.27M $11.63M $11.84M $12.00M $11.05M
Total Assets $28.77M $30.27M $28.90M $28.54M $12.16M $12.32M $12.35M $11.56M
Short-Term Debt $4.55M $4.66M $4.64M $4.35M $3.97M $3.94M $3.90M $1.04M
Other Current Liabilities $273K $273K $273K $272K $265K $254K $284K --
Total Current Liabilities $15.36M $14.76M $14.20M $13.02M $9.65M $7.54M $8.55M $8.68M
Total Non-Current Liabilities $23.04M $24.08M $23.34M $23.87M $9.96M $11.91M $11.94M $9.46M
Total Liabilities $38.40M $38.84M $37.54M $36.89M $19.62M $19.45M $20.49M $18.13M
Total Debt (incl. Leases) $24.20M $24.43M $23.37M $23.25M $14.24M $14.22M $14.19M $10.53M
Common Stock $77.26M $77.26M $77.26M $77.26M $77.29M $77.29M $37.29M $37.29M
Retained Earnings -$46.60M -$45.53M -$45.60M -$45.30M -$44.42M -$44.09M -$43.19M -$42.73M
Total Stockholders' Equity -$9.64M -$8.57M -$8.64M -$8.34M -$7.46M -$7.13M -$8.14M -$6.57M
Total Equity -$9.64M -$8.57M -$8.64M -$8.34M -$7.46M -$7.13M -$8.14M -$6.57M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$2.18M -$2.17M $1.01M $295K -$1.57M $3.08M -$14.96M -$8.18M -$261K -$1.16M
Depreciation & Amortization $812K $467K $499K $540K $325K $121K $217K $274K -- --
Change in Receivables -$923K $183K $78K -$215K $4.3K $106K -- -- -- --
Change in Payables -- -- -- -- -- $301K $1.40M $914K -$232K -$203K
Operating Cash Flow -$33K -$456K -$530K $1.58M -$86K -$102K -$2.90M -$1.46M -$4.1K -$967K
Capital Expenditure -$278K -$60K -$41K -$316K -$133K -- $120K -- -$110K --
Free Cash Flow -$311K -$516K -$571K $1.26M -$218K -- -$2.78M -- -$114K --
Purchases of Investments -$25K -$83K -$389K -- -- -- -- -- -- --
Investing Cash Flow -$254K -$1.01M $2.45M -$712K -$573K -$684K $4.56M -$1.43M -$113K -$26K
Financing Cash Flow $82K $1.68M -$2.08M $304K $590K $854K -$1.95M $3.36M $248K $216K
Net Change in Cash -$185K $176K -$72K $92K -$42K $88K $395K $24K $4.6K -$88K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Net Income -$1.06M $66K -$296K -$885K -$326K -$1.00M -$465K -$374K
Depreciation & Amortization $207K $206K $203K $196K $121K $123K $112K $111K
Change in Receivables $568K -$908K -$490K -$93K $120K -$108K $84K $87K
Operating Cash Flow $306K $124K -$389K -$73K -$78K -$108K -$164K -$106K
Capital Expenditure -$119K -$80K -$66K -$13K $25K -$27K -$26K -$32K
Free Cash Flow $187K $44K -$456K -$86K -$52K -$135K -$190K -$138K
Purchases of Investments $0 $0 -$718 -$25K $0 $0 -$63K -$20K
Investing Cash Flow -$119K -$80K -$67K $12K $25K -$27K -$955K -$52K
Financing Cash Flow -$248K -$363K $667K $27K $260K $160K $1.02M $238K
Net Change in Cash -$55K -$328K $231K -$34K $184K $30K -$106K $69K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -1.4% -22.2% -10.1% 10.1% 0.1% -48.2% -1166.8% -666.9% -- --
Net Profit Margin -11.6% -34.3% 18.8% 6.1% -79.4% 910.0% -4157.0% -1891.0% -- --
Return on Assets (ROA) -7.6% -17.0% 8.7% 4.5% -23.5% 80.7% -466.0% -64.6% -56.7% -395.9%
Current Ratio 0.10x 0.05x 0.05x 0.04x 0.02x 0.07x 0.01x 0.03x 0.08x 0.06x
Quick Ratio 0.10x 0.05x 0.05x 0.04x 0.02x 0.01x 0.01x 0.02x 0.00x 0.05x
Revenue Growth (YoY) +211.9% +12.6% +10.9% +148.2% +473.0% -5.8% -16.8% -- -- --
Operating Income Growth (YoY) -- -- -210.8% +23136.0% -- -- -- -- -- --
Net Income Growth (YoY) -- -305.1% +240.9% -- -150.0% -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -133.6% -- -- -- -- -- -- -269.0%
Free Cash Flow Growth (YoY) -- -- -145.3% -- -- -- -- -- -- --
5Y Revenue / Share Growth +1042.0% -59.4% -59.0% -- -- -- -96.4% -98.0% -- --
10Y Revenue / Share Growth -- -98.5% -99.2% -- -- -- -- -- -- --
5Y Net Income / Share Growth -114.6% -- -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Operating Margin -1.4% 0.0% -10.9% -21.3% -22.2% -33.7% -21.9% -15.8%
Net Profit Margin -11.6% -9.3% -21.5% -31.3% -34.3% -42.8% 12.8% 23.8%
Return on Assets (ROA) -7.6% -4.8% -8.7% -9.0% -17.0% -19.7% 5.5% 11.0%
Current Ratio 0.10x 0.18x 0.14x 0.10x 0.05x 0.06x 0.04x 0.06x
Quick Ratio 0.10x 0.17x 0.14x 0.10x 0.05x 0.06x 0.04x 0.06x
Revenue Growth (YoY) +228.0% +214.2% +229.2% +170.6% +30.4% +30.0% -4.8% 0.0%
Operating Income Growth (YoY) -- -- -- -- -- -2258.5% -963.3% -405.3%
Net Income Growth (YoY) -- -- -- -- -- -147.5% -256.5% --
Operating Cash Flow Growth (YoY) -- -- -- -- -270.4% -- -- -200.1%
Free Cash Flow Growth (YoY) -- -- -- -- -101.0% -- -- -359.0%
Source: SEC EDGAR CompanyFacts (CIK 0000792935) · from December 31, 2011 Data through December 31, 2025 · synced Nov 21, 2026, 05:14 UTC · Open in terminal